Psoriasis Treatment News

psoriasis treatment news
Anacor Pharmaceuticals Announces First Patient Dosed In A Phase 2b Trial Of AN2728 For Psoriasis
Anacor Pharmaceuticals (NASDAQ:ANAC) announced that the first patient has been dosed in a Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide…
Lupus Disease, Lupus Symptoms, Lupus Treatment In The News


Clobex spray improves psoriasis, quality of life in real-world study.(Dermatologic Therapy)(Clinical report): An article from: Skin & Allergy News


Clobex spray improves psoriasis, quality of life in real-world study.(Dermatologic Therapy)(Clinical report): An article from: Skin & Allergy News


$9.95


This digital document is an article from Skin & Allergy News, published by Thomson Gale on April 1, 2007. The length of the article is 512 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Clobex spr…

Tuberculosis testing is essential before starting TNF-antagonist.(Dermatologic Therapy)(tumor necrosis factor antagonist therapy): An article from: Skin & Allergy News


Tuberculosis testing is essential before starting TNF-antagonist.(Dermatologic Therapy)(tumor necrosis factor antagonist therapy): An article from: Skin & Allergy News


$5.95


This digital document is an article from Skin & Allergy News, published by International Medical News Group on September 1, 2004. The length of the article is 465 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation …

Psoriasis therapies score low on European survey.(Dermatologic Therapy): An article from: Skin & Allergy News


Psoriasis therapies score low on European survey.(Dermatologic Therapy): An article from: Skin & Allergy News


$5.95


This digital document is an article from Skin & Allergy News, published by International Medical News Group on July 1, 2004. The length of the article is 448 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation Detai…


You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>